Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans

Doshi, Jalpa A., Zhu, Jingsan, Lee, Bruce Y., Kimmel, Stephen E., Volpp, Kevin G.·2009·Circulation
DOI 10.1161/circulationaha.108.783944

Cited by (184)

Items 101–184 of 184

  1. Effect of Electronic Prescription on Attainment of Cholesterol Goals
    Katherine C. Michelis, Bassel Hassouna, Mina Owlia, Linda C. Kelahan, Heather A. Young, Brian G. Choi · 2011 · Clinical Cardiology
  2. Monitoring the use of lipid-lowering medication among persons with newly diagnosed diabetes: a nationwide register-based study
    Tuulikki Vehko, Reijo Sund, Martti Arffman, Kristiina Manderbacka, Pirjo Ilanne‐Parikka, Ilmo Keskimäki · 2013 · BMJ Open
  3. Risks, benefits, and issues in creating a behind-the-counter category of medications
    L. Douglas Ried, Sally A. Huston, Suzan N. Kucukarslan, Elliott M. Sogol, Kenneth W. Schafermeyer, Sujit S. Sansgiry · 2011 · Journal of the American Pharmacists Association
  4. Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA
    Jae J. Kennedy, Aaron C. Dipzinski, John M. Roll, Joseph S. Coyne, Elizabeth G. Blodgett · 2010 · Drug and Alcohol Dependence
  5. Health Outcome Changes in Individuals With Type 1 Diabetes After a State-Level Insulin Copayment Cap
    Theodoros V. Giannouchos, Benjamin D. Ukert, Thomas C. Buchmueller · 2024 · JAMA Network Open
  6. A randomized controlled trial of co-payment elimination: the CHORD trial.
    Kevin G. M. Volpp, Andrea B. Troxel, Judith A. Long, Said A. Ibrahim, Dina H. Appleby, Jeremy Smith, Jane Jaskowiak, Marie Helweg‐Larsen, Jalpa A. Doshi, Stephen E. Kimmel · 2015 · PubMed
  7. Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis
    Friederike E Thomasius, Santiago Palacios, Asif Alam, Mitra Boolell, Francis Vekeman, Geneviève Gauthier · 2021 · Osteoporosis International
  8. A TEN YEAR OVERVIEW OF SURGICAL AND INTERVENTIONAL ARRHYTHMOLOGY IN RUSSIA. SERVICE PECULIAR FEATURES IN THE FAR EAST
    С А Богачевская, Богачевский Александр Николаевич · 2017 · Social Aspects of Population Health
  9. Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization
    Cinzia Di Novi, Lucia Leporatti, Rosella Levaggi, Marcello Montefiori · 2022 · Journal of Economic Behavior & Organization
  10. The Effect of Opioid Use and Mental Illness on Chronic Disease Medication Adherence in Superutilizers
    Satya Surbhi, Ilana Graetz, Jim Y. Wan, Justin D. Gatwood, James E. Bailey · 2018 · Journal of Managed Care & Specialty Pharmacy
  11. Behavioural economics and health
    Judd B. Kessler, C. Yiwei Zhang · 2015
  12. Alternate Day versus Once Daily Atorvastatin for Primary Prevention of (CHD) in Naïve Patients of Dyslipidemia
    Canna Jagdish Ghia · 2014 · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
  13. Alternate-day versus daily atorvastatin in coronary artery disease: a randomized study
    Osama Rifaie, Ahmed Zahran, Wail Nammas · 2012 · The Anatolian Journal of Cardiology
  14. The Effects of Cost Sharing on Adherence to Medications Prescribed for Concurrent Use: Do Definitions Matter?
    Naomi C. Sacks, James F Burgess, Howard Cabral, Marie Elizabeth McDonnell, Steven D. Pizer · 2015 · Journal of Managed Care & Specialty Pharmacy
  15. Perceived appropriateness of medication adherence incentives
    Tessa J. Hastings, Natalie S. Hohmann, Ruth Ndarake Jeminiwa, Richard A. Hansen, Jingjing Qian, Kimberly B. Garza · 2021 · Journal of Managed Care & Specialty Pharmacy
  16. Supply chain thinking in healthcare: lessons and outlooks
    Lidia Betcheva, Feryal Erhun, Houyuan Jiang · 2020 · Apollo (University of Cambridge)
  17. Veterans Health Administration Healthcare Coverage and Medical Financial Hardship in Low-Income Veterans
    Diana J. Govier, Claire T. Than, Neetu Chawla, Abby Mulcahy, Katherine J. Hoggatt, Elizabeth Martin Yano, Denise M. Hynes · 2023 · American Journal of Preventive Medicine
  18. The Magnitude and Potential Causes of Sex Disparities in Statin Therapy in Veterans with Type 2 Diabetes: A 10-year Nationwide Longitudinal Cohort Study
    Casey H. Buchanan, Elizabeth A. Brown, Kinfe Gebreegziabher Bishu, Erin R. Weeda, Robert Neal Axon, David James Taber, Mulugeta Gebregziabher · 2021 · Women s Health Issues
  19. Does the Association between Prescription Copayment Increases and Medication Adherence Differ by Race?
    Edwin S. Wong, Matthew L. Maciejewski, Chuan‐Fen Liu · 2013 · Journal of Health Care for the Poor and Underserved
  20. Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients
    Yang Sun, Chenze Li, Lína Zhang, Dong Hu, Xudong Zhang, Ting Yu, Min Tao, Dao Wen Wang, Xiaoqing Shen · 2017 · Frontiers of Medicine
  21. Projected Outcomes of Optimized Statin and Ezetimibe Therapy in US Military Veterans with Coronary Artery Disease
    Christopher P. Kovach, Elise C. Mesenbring, Prerna Gupta, Thomas J. Glorioso, P. Michael Ho, Stephen W. Waldo, Gregory G. Schwartz · 2023 · JAMA Network Open
  22. The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
    Robert Patrick Giugliano, Eugene Braunwald · 2011 · Journal of the American College of Cardiology
  23. TREATMENT ADHERENCE AS AN ESSENTIAL ELEMENT OF CARDIOVASCULAR DISORDERS MANAGEMENT
    Д. В. Небиеридзе, T. V. Kamyshova, A. S. Safaryan, V. D. Sargsyan · 2017 · CARDIOVASCULAR THERAPY AND PREVENTION
  24. A comparison of medication adherence between subsidized and self-paying patients in Malaysia.
    H Aziz, Ernieda Hatah, Mohd Makmor‐Bakry, Farida Hanim Islahudin, Najwa Ahmad Hamdi, I-Jen Wan · 2018 · Europe PMC (PubMed Central)
  25. The Effect of Zero Copayments on Medication Adherence in a Community Pharmacy Setting
    Melissa Jimenez, Goar Alvarez, Albert I. Wertheimer, Leanne Lai, Leroy Koh, Dainelys Martinez, Bushra M. Hijazi, Mark D. Weinstein · 2019 · INNOVATIONS in pharmacy
  26. Barriers in utilizing lipid-lowering agents in non-institutionalized population in the U.S.: Application of a theoretical framework
    A. Alfaifi, Leanne Lai, Abdullah Althemery · 2021 · PLoS ONE
  27. The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
    Robert Patrick Giugliano, Eugene Braunwald · 2009 · Journal of the American College of Cardiology
  28. Prescription drug spending and hospital use among Medicare beneficiaries with heart failure
    Blake Tyler McGee, Melinda Kay Higgins, Victoria Phillips, Javed Butler · 2019 · Research in Social and Administrative Pharmacy
  29. COPAGO, conclusiones desde la evidencia científica
    Pascual Solanas, Mercè Marzo‐Castillejo, Elisa Ceresuela Wiesmann, Josep M. Coll Benejam, Joan Gené Badía, Rosa Mª Magallón-Botaya, Ramón Morera Castell, Jesús Sueiro Justel · 2011 · Cadernos de atención primaria
  30. Demographic and clinical factors associated with referrals and compliance to biopsy of oral and maxillofacial lesions
    Rakefet Czerninski, Yehuda Zadik, Marilena Vered, Talia Becker, Ran Yahalom, Estela Derazne, Doron J. Aframian, Galit Almoznino · 2013 · Journal of Oral Pathology and Medicine
  31. Association of smoke‐free laws with preterm or low birth weight deliveries—A multistate analysis
    Xu Ji, Shanna N. Cox, Scott Dennis Grosse, Wanda Denise Barfield, Brian S. Armour, Elizabeth A. Courtney‐Long, Rui Li · 2020 · Health Services Research
  32. The association between lifting an administrative restriction on antidepressant dispensing and treatment patterns in Iceland
    G. Thengilsdóttir, Helga Gardarsdóttir, Anna Birna Almarsdóttir, Christopher Bruce McClure, Eibert Roelof Heerdink · 2013 · Health Policy
  33. Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012
    Miguel Ángel Royo‐Bordonada, José María Lobos Bejarano, F. Villar Alvarez, Susana Sans, Antonio Pérez, Juan Pedro‐Botet, Rosa María Moreno Carriles, Antonio Maiques, Angel Lizcano‐Álvarez, Vicenta Lizarbe et al. · 2013 · Neurología
  34. Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012
    Miguel Ángel Royo‐Bordonada, José María Lobos Bejarano, Fernando Villar Alvarez, Susana Sans, Antonio Pérez, Juan Pedro‐Botet, Rosa María Moreno Carriles, Antonio Maiques, Angel Lizcano‐Álvarez, Vicenta Lizarbe et al. · 2013 · Clínica e Investigación en Arteriosclerosis
  35. Rehabilitation (EACPR) Developed with the special contribution of the European Association for Cardiovascular Prevention & Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) : The Fifth
    Christiaan J. Vrints, David Wood, José Luis Zamorano, Faiez M. Zannad, Şehnaz Karadeniz, Alessandro Mezzani, Eva Prescott, Shah B J Ebrahim, Giuseppe Germanò, Richard F. Hobbs et al. · 2013
  36. Outcome of Secondary Stroke Prevention in Patients Taking Non–Vitamin K Antagonist Oral Anticoagulants
    Taizen Nakase, Junta Moroi, Tatsuya Ishikawa · 2017 · Journal of Stroke and Cerebrovascular Diseases
  37. Predicting Lipid-Lowering Medication Persistence after the First Cardiovascular Disease Hospitalization
    Feiyu Hu, Jim Warren, Daniel John Exeter · 2020 · Methods of Information in Medicine
  38. Comparison of treatment patterns, efficacy and safety between generic and branded atorvastatin users in China: a multicenter, retrospective propensity score-matched cohort study
    Xiaoxuan Xing, Zhizhou Wang, Ke Wang, Yi‐Ming Hua, Xiaoxi Li, Ke-Jia Le, Wenbing Ma, Ying‐Yun Guan, Aiping Deng, Yun Xiong et al. · 2025 · Lipids in Health and Disease
  39. Estimating Lost Revenue From a Free-Care Mandate in the U.S. Department of Veterans Affairs
    Mark W. Smith, Adam Chow, Rachel E. Kimerling · 2010 · Psychiatric Services
  40. Europejskie wytyczne dotyczace zapobiegania chorobom serca i naczyń w praktyce klinicznej na 2012 rok
    Joep Perk, Guy De Backer, H. Gohlke, Ian M Graham, Željko Reiner, W. M. Monique Verschuren, Christian Albus, Pascale Benlian, Gudrun Boysen, Renata Cífková et al. · 2012 · Ghent University Academic Bibliography (Ghent University)
  41. Practical Application of Glaucoma Care in Different Societies
    Alan Lee Robin, Donald L. Budenz, Nathan G. Congdon, R. D. Thulasiraj · 2014 · Elsevier eBooks
  42. Identifying and Managing Treatment Nonadherence
    Jessica El Halabi, William B. Minteer, Kasey R. Boehmer · 2022 · Medical Clinics of North America
  43. Financial hardship after COVID-19 infection among US Veterans: a national prospective cohort study
    Diana J. Govier, David Pham Bui, Katrina E. Hauschildt, Tammy L. Eaton, Holly D. McCready, Valerie A. Smith, Thomas F. Osborne, Christopher Barrett Bowling, Edward J. Boyko, George N. Ioannou et al. · 2024 · BMC Health Services Research
  44. Out‐of‐Pocket Costs and Antihypertensive Medication Use Among Veterans: A Natural Experiment
    Alexander R. Zheutlin, Alexander Chaitoff, Daniel K. Addo, Joshua A. Jacobs, Catherine G. Derington, Eric Lee Stulberg, Peter A. Glynn, Bernardo Modenesi, Jordana B. Cohen, Adam Phillip Bress · 2026 · Journal of the American Heart Association
  45. Assessing the readability of AI-generated medication counseling for common Medicaid drug classes: metformin, lisinopril, and atorvastatin
    Rajat Goel · 2026 · Baylor University Medical Center Proceedings
  46. The Year in Epidemiology, Health Services Research, and Outcomes Research
    Mark Andrew Hlatky, Paul A. Heidenreich · 2011 · Journal of the American College of Cardiology
  47. Medicines Compliance and Reimbursement Level in Portugal
    Maria da Conceição Constantino Portela, Adalberto Campos Fernandes · 2015 · Health Services Research and Managerial Epidemiology
  48. Guidelines and standards in medication adherence research
    Charlotte Linde Bekker, Parisa Aslani, Timothy Frank Chen · 2022 · Elsevier eBooks
  49. Patient Adherence and Duration of Continuous Treatment With Various Arbs in Patients With Uncomplicated Arterial Hypertension in the USA Based on The Analysis of the Truven Health Analytics MarketScan Database
    Yu. N. Belenkov, М. Г. Глезер, Maria V. Kozhevnikova, K. S. Chernichka, Nikolay V. Matveev · 2024 · Kardiologiia
  50. Effectiveness of a Pharmacist-Led Web-Based Medication Adherence Tool With Patient-Centered Communication: Results of a Clustered Randomized Controlled Trial
    Jan van Lieshout, Joyca P. W. Lacroix, Aart van Halteren, Martina Teichert · 2022 · Journal of Medical Internet Research
  51. Methodological Challenges Associated with the Measurement of Medication Adherence in Patients with Cardiovascular Disease
    Antoinette Schoenthaler, Sheba Sethi · 2022 · Springer eBooks
  52. Getting Started: The Benefit of Formulary Decision Support
    Katherine C. Michelis, Brian G. Choi · 2012 · The American Journal of Medicine
  53. Food insecurity, medication utilization, and medication adherence among low-income older adults
    Elisabeth Lilian Pia Sattler · 2013
  54. The impact of untreated psychosis in low and middle income (LAMI) countries and a paradigm for early intervention
    Saeed Farooq · 2012 · Staffordshire Online Repository (Staffordshire University)
  55. Application of cardioprotective medication
    Susan B. Connolly · 2010 · International Journal of Clinical Practice
  56. PMH45 THE ASSOCIATION OF COPAY BURDEN AND MEDICATION ADHERENCE AMONG PATIENTS WITH SCHIZOPHRENIA
    Edward Kim, Sandhya Gupta, SC Bogle, Chih‐Cheng Chen, Richard E. Whitehead, JA Bates · 2009 · Value in Health
  57. Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012
    Miguel Ángel Royo‐Bordonada, José María Lobos Bejarano, Fernando Villar Álvarez, Susana Sans, Antonio Pérez, Juan Pedro‐Botet, Rosa María Moreno Carriles, Antonio Maiques, Angel Lizcano‐Álvarez, Vicenta Lizarbe et al. · 2013 · Avances en Diabetología
  58. Effect of Medicare Part D on the Availability of Medical Treatment for Patients With Glaucoma
    Gregory L. Skuta, Cynthia G. Mattox, Joshua D. Stein · 2015 · JAMA Ophthalmology
  59. Guía europea sobre prevención de la enfermedad cardiovascular en la práctica clínica (versión 2012) Quinto Grupo de Trabajo de la Sociedad Europea de Cardiología y otras Sociedades sobre la Prevención de la Enfermedad Cardiovascular en la Práctica Clínica (constituido por representantes de nueve sociedades y expertos invitados)
    Joep Perk · 2012
  60. Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines
    Miguel Ángel Royo‐Bordonada, José María Lobos Bejarano, F. Villar Alvarez, Susana Sans, Antonio Pérez, Juan Pedro‐Botet, Rosa María Moreno Carriles, Antonio Maiques, Á. Lizcano, Vicenta Lizarbe et al. · 2016 · Neurología (English Edition)
  61. Ghidul european de prevenţie a bolilor cardiovasculare în practica clinică (versiunea 2012) Al Cincilea Comitet al Societăţii Europene de Cardiologie şi a altor Societăţi de Prevenţie a Bolilor Cardiovasculare în Practica Clinică (constituit din reprezentanţi ai nouă societăţi şi experţi invitaţi) Dezvoltat cu contribuţia specială a Asociaţiei Europene pentru Prevenţie şi Reabilitare Cardiovasculară (EACPR)
    Joep Perk · 2014
  62. The trajectory of functional status before and after vascular events
    Mandip S. Dhamoon · 2016
  63. [Assurance-médicaments nationale: Le moment d'aller de l'avant].
    Leila Salehi · 2016 · Europe PMC (PubMed Central)
  64. National pharmacare: Time to move forward.
    Leila Salehi · 2016 · Europe PMC (PubMed Central)
  65. Assurance-médicaments nationale
    Leila Salehi · 2016 · Canadian Family Physician
  66. Medication Nonadherence, Health Care Utilization, and SafeMed Care Transitions Model Impact in Super-Utilizers
    Satya Surbhi · 2016
  67. Comparative Analysis of Alternate Day and Daily Regimen of Atorvastatin in Dyslipidaemic South Indian Patients
    Shanmugasundaram Rajamani, Maharani Balagurumoorthy · 2017 · International Journal of Pharmacology and Clinical Sciences
  68. Improving adherence to high-value medications through prescription cost-sharing policies
    Melissa M. Garrido, Austin B. Frakt · 2018 · BMJ Quality & Safety
  69. Collaboration Is Needed to Improve the Quality of Eye Care and Eliminate Inequities
    Alan Lee Robin · 2018 · JAMA Ophthalmology
  70. Prevenzione cardiovascolare secondaria dopo sindrome coronarica acuta nella pratica clinica. Documento di Consenso delle Società Scientifiche di Medicina Cardiovascolare e Medicina Interna della Regione Lazio
    Furio Colivicchi, Angelo Di Roma, Massimo Uguccioni, Emilio Scotti, Fabrizio Ammirati, Marcello Arca, Aniello Avallone, Orazio Bonaccorso, Giuseppe Germanò, Claudio Letizia et al. · 2010 · Giornale italiano di cardiologia
  71. The social construction of inmates:why some states force inmates to pay for healthcare, and what that means for inmate mortality
    Michael Conner Nicholson · 2019
  72. Circulation's Editors' Picks: Most Important Articles Published Each Week
    The Editors · 2011 · Circulation
  73. Most Read in Circulation: Cardiovascular Quality and Outcomes
    The Editors · 2011 · Circulation
  74. The Year in Epidemiology, Health Services Research, and Outcomes Research
    Mark Andrew Hlatky, Paul A. Heidenreich · 2009 · Journal of the American College of Cardiology
  75. Medication Adherence
    Maureen P. Whitsett, Josh Levitsky · 2021 · Liver Transplantation
  76. Parte II. Combinación de estatina más fibrato (libre y fija)
    2016 · Clínica e Investigación en Arteriosclerosis
  77. Moral Hazard
    Timothy Rice · 2014 · Elsevier eBooks
  78. Benefit Value and Reliance on Veteran Health Administration Coverage
    Yevgeniy Feyman, Allison Dorneo, Steven D. Pizer, Christine A. Yee · 2023 · SSRN Electronic Journal
  79. Medication adherence in patients with carotid artery stenosis before/after enrollment in CARUSO study
    Michela Lanza, Tiziana Claudia Aranzulla, Antonella Cassinari, Giuseppe Musumeci, Andrea Gaggiano, Marianna Farotto, Carlotta Bertolina, Marinella Bertolotti, Antonio Maconi, Alberto Guagliano · 2025 · Working Paper of Public Health
  80. Association of VA Medication Copayment Restructuring With Pharmacy Use, Medication Costs, and Financial Burden of Medications
    Kevin T. Stroupe, Talar W. Markossian, Bella Etingen, Timothy P. Hogan, Beverly González, Charlesnika Tyon Evans, Katie J. Suda, Chad M. Osteen, Ibuola O. Kale, Zhiping Huo et al. · 2025 · Medical Care Research and Review
  81. Uusien lääkkeiden markkinoille tulo ja lääkekustannuksiin vaikuttaminen
    Jaana E. Martikainen · 2012 · Työväentutkimus Vuosikirja
  82. The underutilization of preventive cardiovascular measures in patients with cancer: An analysis of the behavioural risk factor surveillance system, 2011-2022
    Sayed, Ahmed, Munir, Malak, Addison, Daniel, Abushouk, Abdelrahman I, Dent, Susan F, Neilan, Tomas G, Blaes, Anne, Fradley, Michael G, Nohria, Anju, Virani, Salim S. · 2023 · eCommons - AKU (Aga Khan University)
  83. Additional file 1 of Financial hardship after COVID-19 infection among US Veterans: a national prospective cohort study
    Diana J. Govier, David Pham Bui, Katrina E. Hauschildt, Tammy L. Eaton, Holly D. McCready, Valerie A. Smith, Thomas F. Osborne, Bowling, C. Barrett, Edward J. Boyko, Ioannou, George N. et al. · 2024 · Figshare
  84. Harnessing Administrative Data for Policy Evaluation in Labour, Education and Health Economics
    Nuno Crato, Cinzia Di Novi, Elena Claudia Meroni · 2026 · Professional practice in governance and public organizations